TY - JOUR AU - Levine, P. H. AU - Steinhorn, S. C. AU - Ries, L. G. PY - 1985 DA - 1985// TI - Inflammatory breast cancer: the experience of the Surveillance, Epidemiology, and End Results (SEER) program JO - J Natl Cancer Inst VL - 74 ID - Levine1985 ER - TY - JOUR AU - Ismaili, N. PY - 2013 DA - 2013// TI - In regard to Rehman et al JO - Re: Modern outcomes of inflammatory breast cancer. Int J Radiat Oncol Biol Phys VL - 85 ID - Ismaili2013 ER - TY - JOUR AU - Boussen, H. AU - Bouzaiene, H. AU - Ben Hassouna, J. AU - Dhiab, T. AU - Khomsi, F. AU - Benna, F. AU - Gamoudi, A. AU - Mourali, N. AU - Hechiche, M. AU - Rahal, K. AU - Levine, P. H. PY - 2010 DA - 2010// TI - Inflammatory breast cancer in Tunisia: epidemiological and clinical trends JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.25175 DO - 10.1002/cncr.25175 ID - Boussen2010 ER - TY - JOUR AU - Dawood, S. AU - Merajver, S. D. AU - Viens, P. PY - 2011 DA - 2011// TI - International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment JO - Ann Oncol VL - 22 UR - https://doi.org/10.1093/annonc/mdq345 DO - 10.1093/annonc/mdq345 ID - Dawood2011 ER - TY - JOUR AU - Rehman, S. AU - Reddy, C. A. AU - Tendulkar, R. D. PY - 2012 DA - 2012// TI - Modern outcomes of inflammatory breast cancer JO - Int J Radiat Oncol Biol Phys VL - 84 UR - https://doi.org/10.1016/j.ijrobp.2012.01.030 DO - 10.1016/j.ijrobp.2012.01.030 ID - Rehman2012 ER - TY - JOUR AU - Li, J. AU - Gonzalez-Angulo, A. M. AU - Allen, P. K. PY - 2011 DA - 2011// TI - Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer JO - Oncologist VL - 16 UR - https://doi.org/10.1634/theoncologist.2011-0196 DO - 10.1634/theoncologist.2011-0196 ID - Li2011 ER - TY - JOUR AU - Dawood, S. AU - Ueno, N. T. AU - Valero, V. PY - 2011 DA - 2011// TI - Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study JO - Cancer VL - 117 UR - https://doi.org/10.1002/cncr.25682 DO - 10.1002/cncr.25682 ID - Dawood2011 ER - TY - JOUR AU - Gianni, L. AU - Eiermann, W. AU - Semiglazov, V. PY - 2010 DA - 2010// TI - Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(09)61964-4 DO - 10.1016/S0140-6736(09)61964-4 ID - Gianni2010 ER - TY - JOUR AU - Curcio, L. D. AU - Rupp, E. AU - Williams, W. L. PY - 1999 DA - 1999// TI - Beyond palliative mastectomy in inflammatory breast cancerda reassessment of margin status JO - Ann Surg Oncol VL - 6 UR - https://doi.org/10.1007/s10434-999-0249-3 DO - 10.1007/s10434-999-0249-3 ID - Curcio1999 ER - TY - JOUR AU - Incorvati, J. A. AU - Shilpan, S. AU - Ying, M. AU - Janice, L. PY - 2013 DA - 2013// TI - Targeted therapy for HER2 positive breast cancer JO - Journal of Hematology & Oncology VL - 6 UR - https://doi.org/10.1186/1756-8722-6-38 DO - 10.1186/1756-8722-6-38 ID - Incorvati2013 ER - TY - JOUR AU - Harris, E. E. AU - Schultz, D. AU - Bertsch, H. PY - 2003 DA - 2003// TI - Ten-year outcome after combined modality therapy for inflammatory breast cancer JO - Int J Radiat Oncol Biol Phys VL - 55 UR - https://doi.org/10.1016/S0360-3016(02)04201-3 DO - 10.1016/S0360-3016(02)04201-3 ID - Harris2003 ER -